EMEA (Europe, Middle East and Africa) Seasonal Influenza Vaccine Market Report 2017

December 2017 | 115 pages | ID: EBB7885CD0AEN
QYResearch

Abstracts

In this report, the EMEA Seasonal Influenza Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Doses), revenue (Million USD), market share and growth rate of Seasonal Influenza Vaccine for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Seasonal Influenza Vaccine market competition by top manufacturers/players, with Seasonal Influenza Vaccine sales volume (K Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including

• GSK
• Sinovac
• Changsheng
• CCBIO
• Aleph Biomedical
• Sanofi
• Lanzhou Institute Of Biological Product
• Siobp
• Hualan Bio
• Tianyuan Bio-Pharma
• Vaxtec
• Hissen
• Abbott
• Novartis
• Tasly&Jenner
• Tiantan

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Trivalent Influenza Vaccine
• Quadrivalent Influenza Vaccine
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Children
• Adults
• Elderly
• Pregnancy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Seasonal Influenza Vaccine Market Report 2017

1 SEASONAL INFLUENZA VACCINE OVERVIEW

1.1 Product Overview and Scope of Seasonal Influenza Vaccine
1.2 Classification of Seasonal Influenza Vaccine
  1.2.1 EMEA Seasonal Influenza Vaccine Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Seasonal Influenza Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Trivalent Influenza Vaccine
  1.2.4 Quadrivalent Influenza Vaccine
  1.2.5 Other
1.3 EMEA Seasonal Influenza Vaccine Market by Application/End Users
  1.3.1 EMEA Seasonal Influenza Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Children
  1.3.3 Adults
  1.3.4 Elderly
  1.3.5 Pregnancy
1.4 EMEA Seasonal Influenza Vaccine Market by Region
  1.4.1 EMEA Seasonal Influenza Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Seasonal Influenza Vaccine (2012-2022)
  1.5.1 EMEA Seasonal Influenza Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Seasonal Influenza Vaccine Revenue and Growth Rate (2012-2022)

2 EMEA SEASONAL INFLUENZA VACCINE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Seasonal Influenza Vaccine Market Competition by Players/Manufacturers
  2.1.1 EMEA Seasonal Influenza Vaccine Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Seasonal Influenza Vaccine Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Seasonal Influenza Vaccine Sale Price by Players (2012-2017)
2.2 EMEA Seasonal Influenza Vaccine (Volume and Value) by Type/Product Category
  2.2.1 EMEA Seasonal Influenza Vaccine Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Seasonal Influenza Vaccine Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Seasonal Influenza Vaccine Sale Price by Type (2012-2017)
2.3 EMEA Seasonal Influenza Vaccine (Volume) by Application
2.4 EMEA Seasonal Influenza Vaccine (Volume and Value) by Region
  2.4.1 EMEA Seasonal Influenza Vaccine Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Seasonal Influenza Vaccine Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Seasonal Influenza Vaccine Sales Price by Region (2012-2017)

3 EUROPE SEASONAL INFLUENZA VACCINE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Seasonal Influenza Vaccine Sales and Value (2012-2017)
  3.1.1 Europe Seasonal Influenza Vaccine Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Seasonal Influenza Vaccine Revenue and Growth Rate (2012-2017)
3.2 Europe Seasonal Influenza Vaccine Sales and Market Share by Type
3.3 Europe Seasonal Influenza Vaccine Sales and Market Share by Application
3.4 Europe Seasonal Influenza Vaccine Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Seasonal Influenza Vaccine Sales Volume by Countries (2012-2017)
  3.4.2 Europe Seasonal Influenza Vaccine Revenue by Countries (2012-2017)
  3.4.3 Germany Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
  3.4.4 France Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
  3.4.5 UK Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
  3.4.6 Russia Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
  3.4.7 Italy Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)

4 MIDDLE EAST SEASONAL INFLUENZA VACCINE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Seasonal Influenza Vaccine Sales and Value (2012-2017)
  4.1.1 Middle East Seasonal Influenza Vaccine Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Seasonal Influenza Vaccine Revenue and Growth Rate (2012-2017)
4.2 Middle East Seasonal Influenza Vaccine Sales and Market Share by Type
4.3 Middle East Seasonal Influenza Vaccine Sales and Market Share by Application
4.4 Middle East Seasonal Influenza Vaccine Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Seasonal Influenza Vaccine Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Seasonal Influenza Vaccine Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
  4.4.4 Israel Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
  4.4.5 UAE Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
  4.4.6 Iran Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)

5 AFRICA SEASONAL INFLUENZA VACCINE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Seasonal Influenza Vaccine Sales and Value (2012-2017)
  5.1.1 Africa Seasonal Influenza Vaccine Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Seasonal Influenza Vaccine Revenue and Growth Rate (2012-2017)
5.2 Africa Seasonal Influenza Vaccine Sales and Market Share by Type
5.3 Africa Seasonal Influenza Vaccine Sales and Market Share by Application
5.4 Africa Seasonal Influenza Vaccine Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Seasonal Influenza Vaccine Sales Volume by Countries (2012-2017)
  5.4.2 Africa Seasonal Influenza Vaccine Revenue by Countries (2012-2017)
  5.4.3 South Africa Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)

6 EMEA SEASONAL INFLUENZA VACCINE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 GSK
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Seasonal Influenza Vaccine Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GSK Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sinovac
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Seasonal Influenza Vaccine Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sinovac Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Changsheng
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Seasonal Influenza Vaccine Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Changsheng Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 CCBIO
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Seasonal Influenza Vaccine Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 CCBIO Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Aleph Biomedical
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Seasonal Influenza Vaccine Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Aleph Biomedical Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Sanofi
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Seasonal Influenza Vaccine Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sanofi Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Lanzhou Institute Of Biological Product
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Seasonal Influenza Vaccine Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Siobp
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Seasonal Influenza Vaccine Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Siobp Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Hualan Bio
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Seasonal Influenza Vaccine Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Hualan Bio Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Tianyuan Bio-Pharma
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Seasonal Influenza Vaccine Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Vaxtec
6.12 Hissen
6.13 Abbott
6.14 Novartis
6.15 Tasly&Jenner
6.16 Tiantan

7 SEASONAL INFLUENZA VACCINE MANUFACTURING COST ANALYSIS

7.1 Seasonal Influenza Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Seasonal Influenza Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Seasonal Influenza Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Seasonal Influenza Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA SEASONAL INFLUENZA VACCINE MARKET FORECAST (2017-2022)

11.1 EMEA Seasonal Influenza Vaccine Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Seasonal Influenza Vaccine Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Seasonal Influenza Vaccine Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Seasonal Influenza Vaccine Price and Trend Forecast (2017-2022)
11.2 EMEA Seasonal Influenza Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Seasonal Influenza Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Seasonal Influenza Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Seasonal Influenza Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Seasonal Influenza Vaccine Sales Forecast by Type (2017-2022)
11.7 EMEA Seasonal Influenza Vaccine Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Seasonal Influenza Vaccine
Figure EMEA Seasonal Influenza Vaccine Sales Volume (K Doses) by Type (2012-2022)
Figure EMEA Seasonal Influenza Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Trivalent Influenza Vaccine Product Picture
Figure Quadrivalent Influenza Vaccine Product Picture
Figure Other Product Picture
Figure EMEA Seasonal Influenza Vaccine Sales Volume (K Doses) by Application (2012-2022)
Figure EMEA Sales Market Share of Seasonal Influenza Vaccine by Application in 2016
Figure Children Examples
Table Key Downstream Customer in Children
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Elderly Examples
Table Key Downstream Customer in Elderly
Figure Pregnancy Examples
Table Key Downstream Customer in Pregnancy
Figure EMEA Seasonal Influenza Vaccine Market Size (Million USD) by Region (2012-2022)
Figure Europe Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Seasonal Influenza Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Seasonal Influenza Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Seasonal Influenza Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Seasonal Influenza Vaccine Sales Volume and Growth Rate (2012-2022)
Figure EMEA Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Seasonal Influenza Vaccine Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table EMEA Seasonal Influenza Vaccine Sales Volume (K Doses) of Major Players (2012-2017)
Table EMEA Seasonal Influenza Vaccine Sales Share by Players (2012-2017)
Figure 2016 Seasonal Influenza Vaccine Sales Share by Players
Figure 2017 Seasonal Influenza Vaccine Sales Share by Players
Figure EMEA Seasonal Influenza Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Seasonal Influenza Vaccine Revenue (Million USD) by Players (2012-2017)
Table EMEA Seasonal Influenza Vaccine Revenue Share by Players (2012-2017)
Table 2016 EMEA Seasonal Influenza Vaccine Revenue Share by Players
Table 2017 EMEA Seasonal Influenza Vaccine Revenue Share by Players
Table EMEA Seasonal Influenza Vaccine Sale Price (USD/Dose) by Players (2012-2017)
Table EMEA Seasonal Influenza Vaccine Sales (K Doses) and Market Share by Type (2012-2017)
Table EMEA Seasonal Influenza Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Seasonal Influenza Vaccine by Type (2012-2017)
Figure EMEA Seasonal Influenza Vaccine Sales Market Share by Type (2012-2017)
Table EMEA Seasonal Influenza Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Seasonal Influenza Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Seasonal Influenza Vaccine by Type in 2016
Table EMEA Seasonal Influenza Vaccine Sale Price (USD/Dose) by Type (2012-2017)
Table EMEA Seasonal Influenza Vaccine Sales (K Doses) and Market Share by Application (2012-2017)
Table EMEA Seasonal Influenza Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Seasonal Influenza Vaccine by Application (2012-2017)
Figure EMEA Seasonal Influenza Vaccine Sales Market Share by Application in 2016
Table EMEA Seasonal Influenza Vaccine Sales (K Doses) and Market Share by Region (2012-2017)
Table EMEA Seasonal Influenza Vaccine Sales Share by Region (2012-2017)
Figure Sales Market Share of Seasonal Influenza Vaccine by Region (2012-2017)
Figure EMEA Seasonal Influenza Vaccine Sales Market Share in 2016
Table EMEA Seasonal Influenza Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Seasonal Influenza Vaccine Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Seasonal Influenza Vaccine by Region (2012-2017)
Figure EMEA Seasonal Influenza Vaccine Revenue Market Share Regions in 2016
Table EMEA Seasonal Influenza Vaccine Sales Price (USD/Dose) by Region (2012-2017)
Figure Europe Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Europe Seasonal Influenza Vaccine Revenue and Growth Rate (2012-2017)
Table Europe Seasonal Influenza Vaccine Sales (K Doses) by Type (2012-2017)
Table Europe Seasonal Influenza Vaccine Market Share by Type (2012-2017)
Figure Europe Seasonal Influenza Vaccine Market Share by Type in 2016
Table Europe Seasonal Influenza Vaccine Sales (K Doses) by Application (2012-2017)
Table Europe Seasonal Influenza Vaccine Market Share by Application (2012-2017)
Figure Europe Seasonal Influenza Vaccine Market Share by Application in 2016
Table Europe Seasonal Influenza Vaccine Sales (K Doses) by Countries (2012-2017)
Table Europe Seasonal Influenza Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Seasonal Influenza Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Seasonal Influenza Vaccine Sales Market Share by Countries in 2016
Table Europe Seasonal Influenza Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Europe Seasonal Influenza Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Seasonal Influenza Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Seasonal Influenza Vaccine Revenue Market Share by Countries in 2016
Figure Germany Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure France Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure UK Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Russia Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Italy Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Benelux Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Seasonal Influenza Vaccine Sales (K Doses) by Type (2012-2017)
Table Middle East Seasonal Influenza Vaccine Market Share by Type (2012-2017)
Figure Middle East Seasonal Influenza Vaccine Market Share by Type (2012-2017)
Table Middle East Seasonal Influenza Vaccine Sales (K Doses) by Applications (2012-2017)
Table Middle East Seasonal Influenza Vaccine Market Share by Applications (2012-2017)
Figure Middle East Seasonal Influenza Vaccine Sales Market Share by Application in 2016
Table Middle East Seasonal Influenza Vaccine Sales Volume (K Doses) by Countries (2012-2017)
Table Middle East Seasonal Influenza Vaccine Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Seasonal Influenza Vaccine Sales Volume Market Share by Countries in 2016
Table Middle East Seasonal Influenza Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Middle East Seasonal Influenza Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Seasonal Influenza Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Seasonal Influenza Vaccine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Israel Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure UAE Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Iran Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Seasonal Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Seasonal Influenza Vaccine Sales (K Doses) by Type (2012-2017)
Table Africa Seasonal Influenza Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Seasonal Influenza Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Seasonal Influenza Vaccine Sales Market Share by Type in 2016
Table Africa Seasonal Influenza Vaccine Sales (K Doses) by Application (2012-2017)
Table Africa Seasonal Influenza Vaccine Sales Market Share by Application (2012-2017)
Figure Africa Seasonal Influenza Vaccine Sales Market Share by Application (2012-2017)
Table Africa Seasonal Influenza Vaccine Sales Volume (K Doses) by Countries (2012-2017)
Table Africa Seasonal Influenza Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Seasonal Influenza Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Seasonal Influenza Vaccine Sales Market Share by Countries in 2016
Table Africa Seasonal Influenza Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Africa Seasonal Influenza Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Seasonal Influenza Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Seasonal Influenza Vaccine Revenue Market Share by Countries in 2016
Figure South Africa Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Nigeria Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Egypt Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Algeria Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Table GSK Seasonal Influenza Vaccine Basic Information List
Table GSK Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure GSK Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure GSK Seasonal Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure GSK Seasonal Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Sinovac Seasonal Influenza Vaccine Basic Information List
Table Sinovac Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Sinovac Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Sinovac Seasonal Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Sinovac Seasonal Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Changsheng Seasonal Influenza Vaccine Basic Information List
Table Changsheng Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Changsheng Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Changsheng Seasonal Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Changsheng Seasonal Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table CCBIO Seasonal Influenza Vaccine Basic Information List
Table CCBIO Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure CCBIO Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure CCBIO Seasonal Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure CCBIO Seasonal Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Aleph Biomedical Seasonal Influenza Vaccine Basic Information List
Table Aleph Biomedical Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Aleph Biomedical Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Aleph Biomedical Seasonal Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Aleph Biomedical Seasonal Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Sanofi Seasonal Influenza Vaccine Basic Information List
Table Sanofi Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Sanofi Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Sanofi Seasonal Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Sanofi Seasonal Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Basic Information List
Table Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Siobp Seasonal Influenza Vaccine Basic Information List
Table Siobp Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Siobp Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Siobp Seasonal Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Siobp Seasonal Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Hualan Bio Seasonal Influenza Vaccine Basic Information List
Table Hualan Bio Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Hualan Bio Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Hualan Bio Seasonal Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Hualan Bio Seasonal Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Tianyuan Bio-Pharma Seasonal Influenza Vaccine Basic Information List
Table Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Tianyuan Bio-Pharma Seasonal Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Vaxtec Seasonal Influenza Vaccine Basic Information List
Table Hissen Seasonal Influenza Vaccine Basic Information List
Table Abbott Seasonal Influenza Vaccine Basic Information List
Table Novartis Seasonal Influenza Vaccine Basic Information List
Table Tasly&Jenner Seasonal Influenza Vaccine Basic Information List
Table Tiantan Seasonal Influenza Vaccine Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Seasonal Influenza Vaccine
Figure Manufacturing Process Analysis of Seasonal Influenza Vaccine
Figure Seasonal Influenza Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Seasonal Influenza Vaccine Major Manufacturers in 2016
Table Major Buyers of Seasonal Influenza Vaccine
Table Distributors/Traders List
Figure EMEA Seasonal Influenza Vaccine Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure EMEA Seasonal Influenza Vaccine Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Seasonal Influenza Vaccine Price (USD/Dose) and Trend Forecast (2017-2022)
Table EMEA Seasonal Influenza Vaccine Sales (K Doses) Forecast by Region (2017-2022)
Figure EMEA Seasonal Influenza Vaccine Sales Market Share Forecast by Region (2017-2022)
Table EMEA Seasonal Influenza Vaccine Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Seasonal Influenza Vaccine Revenue Market Share Forecast by Region (2017-2022)
Table Europe Seasonal Influenza Vaccine Sales (K Doses) Forecast by Countries (2017-2022)
Figure Europe Seasonal Influenza Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Seasonal Influenza Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Seasonal Influenza Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Seasonal Influenza Vaccine Sales (K Doses) Forecast by Countries (2017-2022)
Figure Middle East Seasonal Influenza Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Seasonal Influenza Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Seasonal Influenza Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Seasonal Influenza Vaccine Sales (K Doses) Forecast by Countries (2017-2022)
Figure Africa Seasonal Influenza Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Seasonal Influenza Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Seasonal Influenza Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Seasonal Influenza Vaccine Sales (K Doses) Forecast by Type (2017-2022)
Figure EMEA Seasonal Influenza Vaccine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Seasonal Influenza Vaccine Sales (K Doses) Forecast by Application (2017-2022)
Figure EMEA Seasonal Influenza Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources